Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias

Thrombosis Research

Volumn 72, Issue 4, 1993, Pages 295-304

  Lee, Young J ^a   Jy, Wenche ^a   Horstman, Lawrence L ^a   Janania, Jamal ^a   Reyes, Yolanda ^a   Kelley, Roger E ^a   Ahn, Yeon S ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

calcium channel blocker; dementias; lacunar infarcts; platelet activation; platelet microparticles; TIA

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM CHANNEL BLOCKING AGENT; DIPYRIDAMOLE; NIFEDIPINE;

ADULT; ALZHEIMER DISEASE; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE RELEASE REACTION; THROMBOCYTOPENIC PURPURA; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGED; ALZHEIMER DISEASE; BLOOD PLATELETS; CEREBRAL INFARCTION; DEMENTIA, MULTI-INFARCT; FEMALE; HUMAN; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGE; NIFEDIPINE; PARTICLE SIZE; SUPPORT, NON-U.S. GOV'T;

EID: 0027495262     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(93)90138-E     Document Type: Article

References (28)

1. Role of calcium and calpain in complement-induced vesiculation of the platelet membrane and in the exposure of the platelet factor Va receptor
2. Stimulation and inhibition of platelet membrane fragmentation
3. Complement proteins C5-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation Factor Va and express prothrombinase activity
4. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane
5. Association of factor V activity with membranous vesicles released from human platelets: Requirement for platelet stimulation
6. Expression of coagulant activity in human platelets: Release of membranous vesicles providing platelet factor 1 and platelet factor 3
7. Clinical significance of platelet microparticles in autoimmune thrombocytopenia
8. Elevated platelet microparticles in multiinfarct dementias and transient ischemic attacks
9. Platelet activation and coronary ischemic syndromes
10. Platelet surface glycoproteins
11. Direct detection of activated platelets and platelet-derived microparticles in humans
12. Vesiculation of platelets during in vitro aging
13. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura
14. Mechanisms of platelet fragmentation in immune thrombocytopenias: Role of complement
15. The release of vesicles from platelets following adhesion to vessel walls in vitro
16. The adhesive dendritic pseudopodium of the platelet and the release reaction
17. Pathogenesis of thrombosis
18. Platelet aggregation, stroke and transient ischemic attack in middle-aged and elderly patients
19. Platelet activation in acute cerebral ischemia
20. Increased platelet aggregates in patients with transient ischemic attacks
21. Increased platelet calcium in thrombosis and related disorders and its correction by nifedipine
22. Baseline and activated platelet cytoplasmic ionized calcium in acute ischemic stroke: Effect of aspirin
23. Platelet alpha granule secretion in cerebral ischemia: Effect of short and long term low dose aspirin treatment
24. Enhanced “in vivo” platelet activation in subtypes of ischemic stroke
25. Platelet ultrastructure and secretion in acute ischemic stroke
26. Role of the membrane skeleton in preventing the shedding of procoagulant rich microvesicles from the platelet plasma membrane
27. Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brain
28. Platelet microvesicles adhere to subendothelium and promote adhesion of platelets